Experts highlight treatment advances and challenges ahead in OA, RA, and systemic lupus erythematosus (SLE)
ACR 2013 State-of-the-Art Clinical Symposium: Diagnosis and Management of Vasculitis
The latest on Behçet’s syndrome, infectious arthritis, and central nervous system vasculitis
New Methodology to Improve Cartilage Repair
A single treatment with recombinant acid ceramidase improves the chondrogenic phenotype of primary chondrocytes and leads to an increased yield of mesenchymal stem cells. (posted July 31, 2013)
B-Cell Genes Interact to Increase Risk for Rheumatoid Arthritis
Researchers demonstrate that BANK1 is a susceptibility gene for RA, and it may play a role in RA pathogenesis. (posted June 31, 2013)
Letters: Don’t Forget Lyme Disease When Considering Polymyalgia Rheumatica
Lyme disease may present the identical clinical picture to PMR and must be ruled out
California Rheumatology Alliance 2013 Meeting: Rheumatologists Advised to Drop Prednisone Maintenance Therapy in Lupus Patients
A systemic lupus erythematosus (SLE) disease expert emphasizes benefits of hydroxychloroquine, burst of steroid treatments
California Rheumatology Alliance 2013 Meeting: Aim for Remission in Rheumatoid Arthritis
Early diagnosis and aggressive treatment of RA is key, expert says
California Rheumatology Alliance 2013 Meeting: The Future of Rheumatoid Arthritis
Treatment for RA should involve targeting subclinical disease and reversing immune dysregulation, expert says
Researchers Explore HLA-B27’s Role in the Development of Spondylitis
New research reports on the increased sensitivity of human-HLA-B27 transgenic rat bone marrow monocytes to TNF-α stimulation and osteoclast differentiation. (posted June 27, 2013)
Can Lubricating Joints Prevent Osteoarthritis?
Proteoglycan 4 (Prg4), also known as lubricin, could slow the process of cartilage destruction in osteoarthritis. (posted June 13, 2013)
- « Previous Page
- 1
- …
- 282
- 283
- 284
- 285
- 286
- …
- 334
- Next Page »